{"studyId":"prad_cdk12_mskcc_2020","cancerTypeId":"prad","name":"Prostate Adenocarcinoma (MSK, Eur Urol 2020)","description":"Targeted sequencing of 1465 prostate adenocarcinoma tumor/normal pairs via MSK-IMPACT.","publicStudy":true,"pmid":"32317181","citation":"Nguyen et al. Eur Urol 2020","groups":"","status":1,"importDate":"2026-01-13 10:11:17","allSampleCount":1465,"sequencedSampleCount":1465,"cnaSampleCount":1465,"mrnaRnaSeqSampleCount":0,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":0,"completeSampleCount":0,"referenceGenome":"hg19","treatmentCount":1,"structuralVariantCount":626,"cancerType":{"id":"prad","name":"Prostate Adenocarcinoma","dedicatedColor":"Cyan","shortName":"PRAD","parent":"prostate"},"readPermission":true,"resourceCounts":[]}